Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(AH, GTXI, CRWE, RNF) Stock Market Report


Accretive Health, Inc. (NYSE:AH), a leading provider of services to healthcare providers reported that the Company will hold a conference call for investors on Wednesday, November 7, 2012, at 7:30 am central time.

During the conference call, management will review highlights from the Company’s third quarter and year to date 2012 results, which will be announced via press release one hour prior to the call, and will discuss the Company’s operations and business outlook.


The use of videos on the Internet brings numerous advantages. It is a great solution with great impact on the visitor.

Crown Equity Holdings Inc., (OTCPK:CRWE) recenly launched CRWE Tube,, a video sharing site that allows billions of people around the world to upload, watch and share original videos.

Restricting your marketing to just written text vastly limits your audience; video marketing should be seen as another mode of online communication to reach potential customers.

CRWE offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them.

CRWE‘s advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.

More about CRWE at


GTx, Inc. (NASDAQ:GTXI) reported there will be two scientific poster presentations on the effects of enobosarm, a selective androgen receptor modulator (SARM), on improving physical function and quality of life in middle aged and elderly cancer patients.

The posters will be displayed on October 26th and 27th, 2012, at the 12th Meeting of the International Society of Geriatric Oncology to be held at the Manchester Central Convention Centre in Manchester, United Kingdom. Ryan P. Taylor, PhD, GTx’s Associate Director of Medical Affairs, will present data from the company’s Phase IIb clinical study of enobosarm, providing evidence that enobosarm may play an important role in the management of cancer patients with muscle wasting by improving physical function and quality of life, regardless of baseline weight loss or age.


Rentech Nitrogen Partners, L.P. (NYSE:RNF) reported that the Partnership will hold its 2012 third quarter conference call on Thursday, November 8, 2012 at 9:00 a.m. PST, during which time senior management will review the Partnership's financial results for the period and provide an update on the business.



Disclaimer: publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. (Read Full Disclaimer at

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.